Related Experiment Video

Updated: Jun 13, 2026

Refined Murine Model of Idiopathic Pulmonary Fibrosis
07:51

Refined Murine Model of Idiopathic Pulmonary Fibrosis

Published on: June 17, 2025

Pathologic caveolin-1 regulation of PTEN in idiopathic pulmonary fibrosis

Hong Xia1, Wajahat Khalil, Judy Kahm

  • 1Department of Medicine, University of Minnesota, 420 Delaware Street SE, Minneapolis, MN 55455, USA.

The American Journal of Pathology
|April 17, 2010
PubMed

Insights

Idiopathic pulmonary fibrosis (IPF) involves fibroblast overgrowth due to low PTEN activity. Low caveolin-1 reduces membrane PTEN, promoting pathological proliferation in IPF.

Area of Science:

  • Cell Biology
  • Pulmonary Medicine
  • Biochemistry

Background:

  • Idiopathic pulmonary fibrosis (IPF) is a progressive lung disease with limited treatment options.
  • IPF fibroblasts exhibit abnormal PI3K/Akt pathway activation due to reduced PTEN phosphatase activity.
  • Decreased membrane-associated PTEN and low caveolin-1 expression are observed in IPF.

Purpose of the Study:

  • To investigate the role of caveolin-1 in regulating PTEN function within IPF fibroblasts.
  • To determine if caveolin-1 deficiency contributes to the aberrant PI3K/Akt signaling in IPF.

Main Methods:

  • Examined the correlation between caveolin-1 and PTEN levels in IPF fibroblasts.
  • Investigated the interaction between PTEN and caveolin-1 using its binding sequence.
  • Assessed the effect of caveolin-1 overexpression on PTEN localization, Akt phosphorylation, and fibroblast proliferation.

Main Results:

  • Caveolin-1 expression levels directly influence membrane-associated PTEN levels.
  • PTEN interacts with caveolin-1 through its specific binding sequence.
  • Low caveolin-1 in IPF fibroblasts leads to reduced membrane PTEN, promoting PI3K/Akt activation and proliferation.
  • Overexpressing caveolin-1 restored membrane PTEN, inhibited Akt phosphorylation, and suppressed proliferation.

Conclusions:

  • Low caveolin-1 expression in IPF fibroblasts causes decreased membrane PTEN, impairing inhibitory phosphatase activity.
  • This creates a pro-proliferative microenvironment by enabling aberrant PI3K/Akt activation in IPF.
  • Targeting caveolin-1 may offer a therapeutic strategy for idiopathic pulmonary fibrosis.

More Related Videos

Phenotyping Mouse Pulmonary Function In Vivo with the Lung Diffusing Capacity07:13

Phenotyping Mouse Pulmonary Function In Vivo with the Lung Diffusing Capacity

Published on: January 6, 2015

Related Concept Videos

Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Pulmonary Hypertension: Classification and Pathogenesis01:30

Pulmonary Hypertension: Classification and Pathogenesis

Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
Chronic Obstructive Pulmonary Disease II: Emphysema01:23

Chronic Obstructive Pulmonary Disease II: Emphysema

Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...